Butterfly Network gains FDA clearance for its AI-powered gestational age tool, boosting prenatal imaging and enabling faster, ...
The Butterfly iQ3 is a handheld ultrasound device that connects to a compatible smartphone or tablet to provide real-time ...
AI drug developer Insilico Medicine and Lilly ink commercialization deal worth up to $2.75 billion ( STAT) AstraZeneca’s in ...
Butterfly Network announced that it received FDA clearance for a fully automated gestational age (GA) tool for its handheld ...
A summary of recent advancements and obstacles in health and pharmaceutical sectors includes Germany's proposals to cap statutory health insurance costs, Insilico Medicine's AI partnership with Eli ...
Recent developments in the health sector include Germany's proposal to curb health insurance costs, Insilico Medicine's AI-driven drug deal with Eli Lilly, Butterfly Network's FDA approval for an AI ...
Butterfly Network, Inc. ("Butterfly," "the Company") (NYSE: BFLY), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced it has received ...
Butterfly’s GA tool within its point-of-care ultrasound (POCUS) system is intended for rollout in regions with socioeconomic ...
HistoSonics announced the first successful treatments in a study of its Edison histotripsy system for benign prostatic hyperplasia (BPH).
Butterfly Network said on Monday it received U.S. regulatory clearance for an artificial intelligence-powered ultrasound tool ...
Statistical significance achieved with new high dose-combination despite small sample size; Results validate dose selection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results